Key Takeaways
- The Seattle Seahawks secured their second Super Bowl title, defeating the New England Patriots 29-13.
- Chinese regulators advised financial institutions to limit US Treasury holdings over concentration risks and market volatility.
- Japanese Prime Minister Sanae Takaichi's party achieved a historic election supermajority, strengthening her leadership.
- Novo Nordisk shares surged after a competitor ceased offering a copycat version of its weight-loss drug Wegovy.
Deep Dive
- The Seattle Seahawks defeated the New England Patriots 29-13 in Super Bowl LX at Levi's Stadium.
- Seahawks running back Kenneth Walker III was named Super Bowl MVP, marking the first time a running back won since 1998.
- The team's defense recorded six sacks and two interceptions against Patriots quarterback Drake Maye.
- Bad Bunny made history as the first Spanish-language artist to headline the halftime show, attracting significant Latino viewership.
- Chinese regulators have advised financial institutions to reduce their holdings of US Treasuries.
- The directive cites concerns over concentration risks and market volatility for these holdings.
- The guidance was verbally communicated to some of China's biggest banks, but does not apply to state holdings of US Treasuries.
- Despite these warnings, overseas holdings of Treasuries advanced to a record high in November, with countries like Norway and Saudi Arabia offsetting declines from China.
- Prime Minister Sanae Takaichi's Liberal Democratic Party (LDP) secured a historic two-thirds supermajority in Japan's 465-seat lower house.
- The LDP won 316 seats, representing the biggest post-war victory for a single party in a general election.
- This outcome solidifies Takaichi's position as the nation's strongest post-war leader, bolstering her economic policies.
- A Department of Homeland Security funding deadline is approaching, triggering legislative debate in Washington.
- Democrats and Republicans are at odds over proposed immigration enforcement reforms.
- Key points of contention include proposals for amnesty and restrictions on Immigration and Customs Enforcement (ICE).
- Novo Nordisk shares surged over 8% after Hims and Hers Health announced it would stop offering a copycat version of the weight-loss drug Wegovy.
- Hims and Hers shares fell nearly 15% in pre-market trading following their decision.
- The move by Hims and Hers aligns with the FDA's pledge to crack down on unauthorized copycat pharmaceutical products.